Table 5. The comparison of the original and the newly refined IgAN risk score.
Original Risk Score | Newly Refined Risk Score | ||||||||
Cohort: | N# | R2 * | C** | OR*** | P-value**** | R2 * | C** | OR*** | P-value**** |
Original GWAS Cohorts | 5,631 | 5.0% | 0.61 | 1.51 | 3.1×10−46 | 5.7% | 0.62 | 1.56 | 4.1×10−52 |
Replication Cohorts | 4,422 | 2.2% | 0.58 | 1.29 | 5.4×10−17 | 3.2% | 0.59 | 1.36 | 3.3×10−24 |
Asian Cohorts Combined | 4,582 | 4.5% | 0.60 | 1.53 | 3.0×10−34 | 5.0% | 0.61 | 1.52 | 2.6×10−38 |
European Cohorts Combined | 5,386 | 2.6% | 0.58 | 1.34 | 3.7×10−24 | 3.6% | 0.59 | 1.42 | 6.7×10−33 |
All Cohorts Combined | 10,053 | 3.8% | 0.60 | 1.42 | 6.2×10−63 | 4.7% | 0.61 | 1.47 | 1.2×10−76 |
The expanded version of this table can be found in supplemental material (Table S7).
Number of analyzed individuals with 100% non-missing genotypes across all 7 scored loci.
*: 2: Nagelkerke R square (expressed as percentage).
**: C-statistic: area under the ROC curve.
***: Odds ratio per one standard deviation of the standardized risk score.
****: Wald's test for risk score as a quantitative predictor of disease status.